Emami (531162) Aktienübersicht
Emami Limited produziert und vermarktet Körperpflege- und Gesundheitsprodukte in Indien und international. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 2/6 |
| Vergangene Leistung | 3/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 6/6 |
Belohnungen
Risikoanalyse
Bei unseren Risikoprüfungen wurden keine Risiken für 531162 festgestellt.
531162 Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Emami Limited Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | ₹444.65 |
| 52-Wochen-Hoch | ₹655.40 |
| 52-Wochen-Tief | ₹385.35 |
| Beta | 0.12 |
| 1 Monat Veränderung | 11.68% |
| 3 Monate Veränderung | -6.40% |
| 1 Jahr Veränderung | -29.26% |
| 3 Jahre Veränderung | 17.65% |
| 5 Jahre Veränderung | -7.85% |
| Veränderung seit IPO | 18,888.63% |
Aktuelle Nachrichten und Updates
531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).
531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).
531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.Recent updates
531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Aktionärsrenditen
| 531162 | IN Personal Products | IN Markt | |
|---|---|---|---|
| 7D | -3.4% | -2.8% | 0.4% |
| 1Y | -29.3% | -5.8% | 4.0% |
Rendite im Vergleich zur Industrie: 531162 unter dem Niveau der Branche Indian Personal Products , die im vergangenen Jahr eine Rendite von -5.8% erzielte.
Rendite vs. Markt: 531162 hinter dem Markt Indian zurück, der im vergangenen Jahr eine Rendite von 4 erzielte.
Preisvolatilität
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 4.2% |
| Personal Products Industry Average Movement | 5.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stabiler Aktienkurs: 531162 hatte in den letzten 3 Monaten im Vergleich zum Indian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: 531162Die wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1974 | 3,217 | Harsha Agarwal | www.emamiltd.in |
Emami Limited produziert und vermarktet Körperpflege- und Gesundheitsprodukte in Indien und international. Unter der Marke Boroplus bietet das Unternehmen ayurvedische antiseptische Creme, Stachelhitzepulver, Doodh Kesar Körperlotion, Aloe Neem Lotion, Vasocare Herbal Petroleum Jelly, Kokosnussöl, Aloe Vera Gel und Hygieneprodukte an; Cool Oil, Extra Thanda, Gold Ayurvedic Oil, Therapy Ayurvedic Body Massage and Stress Relief Oil, Maxx Cool Talk und Cool Talk unter der Marke Navratna; und Balm, Balm Ultra-Power, Quick Relief Roll-On, Ortho Vedic Oil, Salbe, Relief Gel und Spray, Healthcare Products, Pancharishta, Nityam und Kesari Jivan unter der Marke Zandu. Außerdem bietet das Unternehmen unter der Marke Fair and Handsome Strahlungscreme und Instant Radiance Face Wash für Männer an; Haarpflegeprodukte und Shampoo unter der Marke Kesh King; Balsam unter der Marke Mentho Plus; Stachelhitzepulver unter der Marke Dermicool; Haaröl, Shampoos und Conditioner unter der Marke Emami 7 Oils in One; Deodorants unter der Marke HE; Haarfarben unter der Marke Emami Diamond Shine; Talk unter der Marke Emami Golden Beauty; pflanzliche Schönheitscreme unter der Marke Emami Naturally Fair; Zahnpasta unter der Marke Ayucare; Haarfarben und -öle unter der Marke Emami Gold; und Feuchtigkeitscremes, Lotionen, Softcremes, Glycerincremes und -öle, Vaseline, Babyshampoos und andere Hautprodukte unter der Marke Cream21.
Emami Limited's Grundlagenzusammenfassung
| 531162 grundlegende Statistiken | |
|---|---|
| Marktanteil | ₹194.09b |
| Gewinn(TTM) | ₹7.94b |
| Umsatz(TTM) | ₹38.17b |
Ist 531162 zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| 531162 Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | ₹38.17b |
| Kosten der Einnahmen | ₹12.13b |
| Bruttogewinn | ₹26.04b |
| Sonstige Ausgaben | ₹18.10b |
| Gewinn | ₹7.94b |
Zuletzt gemeldete Gewinne
Dec 31, 2025
Datum des nächsten Gewinnberichts
May 21, 2026
| Gewinn per Aktie (EPS) | 18.20 |
| Bruttomarge | 68.22% |
| Nettogewinnspanne | 20.81% |
| Schulden/Eigenkapital-Verhältnis | 2.5% |
Wie hat sich 531162 auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/02 11:09 |
| Aktienkurs zum Tagesende | 2026/04/30 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Emami Limited wird von 49 Analysten beobachtet. 21 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |